clinical trial · NCT06431815
ADVENT Post Approval Study
Paroxysmal Atrial FibrillationFARAPULSE™ Pulsed Field Ablation System
brief summary
The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.
started
Sep 25, 2024
primary completion
Oct 1, 2028
completion
Oct 1, 2029
last updated
Jun 30, 2026
detailed description
The objective of ADVENT PAS is to evaluate the long-term safety and effectiveness profile of the FARAPULSE Pulsed Field Ablation System when used to perform pulmonary vein isolation (PVI) in the de-novo ablation treatment of patients with paroxysmal atrial fibrillation (PAF).
official title
Prospective, Multi-site Safety and Effectiveness Post-Approval Study of FARAPULSE Pulsed Field Ablation in Paroxysmal Atrial Fibrillation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol